This is the authors' abstract. We don't add key points for this paper.
Conventional co-precipitation synthesis of Fe-based Prussian Blue cathodes relies on controlled precursor feeding, chelating agents, sodium-compensating salts, and inert atmospheres to regulate crystallization and suppress defects. Here, a simplified one-pot strategy is developed in which ascorbic acid regulates ferrous phosphate (Fe 3 (PO 4 ) 2 ) dissolution and enables gradual Fe-ion release. Studies of reaction time and ascorbic acid dosage indicate that mild acidity, reducing conditions, and possible Fe-ascorbate coordination jointly moderate dissolution and the subsequent reaction with sodium ferrocyanide. This method produces Fe-based Prussian Blue with high sodium content, low vacancy concentration, and low water content, without slow precursor feeding, inert-atmosphere protection, or additional chelating and sodium-compensating agents. Thermally activated PBA-044 delivers an initial discharge capacity of 104.6 mAh g −1 at 0.2 C and retains 84.5 % of its capacity after 500 cycles at 5 C. Tests using various acidic media and iron-based precursors demonstrate the broader feasibility of dissolution-regulated synthesis, although product quality depends on acid strength, coordination ability, precursor solubility, and particle characteristics. This work provides a practical strategy for simplifying the synthesis of Fe-based Prussian Blue cathodes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: